To elucidate the molecular mechanisms underlying the pathogenesis of AML, Figure 2 depicts the normal FLT3 signaling pathways involved in hematopoiesis and the dysregulated signaling pathways caused by FLT3 mutations in AML. This evidence concerns the gene FLT3 and acute myeloid leukemia.